Neumora Therapeutics
Price & Volume
Stats
See moreOpen | $0.75 |
Previous Close | $0.73 |
Day Range | $0.69-$0.75 |
52W Range | $0.68-$3.65 |
Market Cap | $137.4M |
Shares Short | 8M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$1.38 |
News
See moreYahoo Finance • 7 days ago
Biotech Options Buzz: UTHR, NMRA, EWTX
Yahoo Finance • 20 days ago
ANI Pharmaceuticals (ANIP) Appoints Henry Gosebruch To Its Board
Yahoo Finance • 25 days ago
Johnson & Johnson Owns Stakes in 15 Stocks. Here's the Best of the Bunch.
Yahoo Finance • 2 months ago
Neumora Reports Positive Toxicology Data For NMRA-215; IND Planned For Q4 '26
About
CEO | Dr. Joshua Pinto Ph.D. |
CFO | Mr. Michael Lee Milligan |
Address | 260 Arsenal Place, Watertown, MA, United States, 02472 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 63 |